{{facet.count}}
{{facet.count}}
{{facet.count}}
{{facet.count}}
{{facet.count}}
{{facet.count}}
{{facet.count}}
{{facet.count}}
{{facet.count}}
{{facet.count}}
{{facet.count}}
{{facet.count}}
{{facet.count}}
{{facet.count}}
{{facet.count}}
{{facet.count}}
{{facet.count}}
{{facet.count}}
{{facet.count}}
{{facet.count}}
{{facet.count}}
{{facet.count}}
{{facet.count}}
{{facet.count}}
{{facet.count}}
{{facet.count}}
{{facet.count}}
{{facet.count}}
{{facet.count}}
{{facet.count}}
{{facet.count}}
{{facet.count}}
{{facet.count}}
{{facet.count}}
Search results for glutathione root_names_stdName in Standardized Name (approximate match)
Status:
Investigational
Source:
NCT04087018: Phase 1 Interventional Completed Advanced Solid Tumors
(2019)
Source URL:
Class:
PROTEIN
Status:
Investigational
Source:
NCT02877134: Phase 2 Interventional Completed Crohn Disease
(2016)
Source URL:
Class:
PROTEIN
Status:
Investigational
Source:
NCT03938935: Not Applicable Interventional Unknown status Flexor Tendon Repair
(2019)
Source URL:
Class:
PROTEIN
Status:
Investigational
Source:
NCT04501939: Phase 2 Interventional Active, not recruiting Chronic Lymphocytic Leukemia
(2020)
Source URL:
Class:
PROTEIN
Status:
Investigational
Source:
INN:briquilimab [INN]
Source URL:
Class:
PROTEIN
Status:
Investigational
Source:
NCT04297995: Phase 2 Interventional Active, not recruiting Head and Neck Squamous Cell Carcinoma
(2020)
Source URL:
Class:
PROTEIN
Status:
Investigational
Source:
INN:pivekimab sunirine [INN]
Source URL:
Class:
PROTEIN
Status:
Investigational
Source:
NCT04669899: Phase 1/Phase 2 Interventional Completed Cancer
(2021)
Source URL:
Class:
PROTEIN
Status:
Investigational
Source:
NCT03481946: Phase 1 Interventional Completed Hemophilia A; Hemophilia B
(2018)
Source URL:
Class:
PROTEIN
Status:
Investigational
Source:
INN:lorigerlimab [INN]
Source URL:
Class:
PROTEIN